🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neutropenia is a common complication from dalpiciclib. Mecapegfilgramtim (c...
Status
Active Not Recruiting
Location
中山大学中山纪念医院
Start Date
2022-08-01
Trial ID
NCT05463601
Treatments Being Tested
The investigators' purpose was to assess the feasibility of dosage individu...
Status
Recruiting
Location
Department of Pediatrics, the Affiliated Hospital of Xuzhou Medical University
Start Date
2016-01-31
Trial ID
NCT03844360
This study utilizes a prospective, multicenter, randomized two-arm design t...
Status
Recruiting
Location
Dongyang People's Hospital
Start Date
2024-08-01
Trial ID
NCT06520163
Treatments Being Tested
The purpose of this study is to assess the efficacy of selumetinib in combi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2013-09-25
Trial ID
NCT01933932
Treatments Being Tested
This phase IV trial compares the effect of premedication regimens with meth...
Status
Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2025-09-24
Trial ID
NCT07101445
Currently, adjuvant therapy is not recommended for patients with esophageal...
Status
Recruiting
Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2018-11-01
Trial ID
NCT03731442
Treatments Being Tested
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-05-08
Trial ID
NCT06738368
This initial cohort of this phase II trial studied the outcomes of using a ...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-02-09
Trial ID
NCT04370301
Treatments Being Tested
This is a Phase II, open-label, seven-arm parallel study evaluating the eff...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2022-06-30
Trial ID
NCT05076682
This is an open-label, single ascending dose study to evaluate safety, tole...
Status
Completed
Location
Seoul National University Hospital
Start Date
2016-10-04
Trial ID
NCT02963389
Treatments Being Tested